Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |
mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.001 |
mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | MP470 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
mRNA | oligomycin a | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |
mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.003 |